Roundtable Report Highlights Importance of Immunizing Canada’s Caregivers Against Influenza, Identifying Challenges and Opportunities to Protect This Critical Group

Experts agreed that caregivers are essential to the Canadian healthcare system and economy, yet their importance often goes underrecognized, even by caregivers themselves.

New York, NEW YORK (June 1, 2022)—The Global Coalition on Aging (GCOA) today released a report summarizing key insights from an expert roundtable on vaccinating Canada’s caregivers against influenza. The roundtable, held virtually, brought together leading Canadian health policy experts, family caregivers, patient advocacy groups, aging experts, and other thought leaders to discuss challenges and strategies to reach this critically important yet hard-to-reach group.

Around 8 million Canadians provide care to a family member or friend, many of whom are medically vulnerable. At the same time, only 42% of Canadian adults received an influenza vaccine during the two seasons prior to the start of the COVID-19 pandemic, with the full impact of influenza widely underrecognized. Research shows that a case of influenza leads to a tenfold increase in the risk of a first heart attack and an eightfold increase in stroke risk in the few days following an infection.

“Influenza can have a devastating impact,” explained Michael Hodin, CEO of the Global Coalition on Aging.Each year, influenza increases hospital admissions and overcrowds emergency departments, creating unsafe conditions and crippling the healthcare system, while leading to a cascade of decline in many previously healthy adults. Vaccination is one of the most cost-effective and accessible ways that caregivers can protect their own health as well as that of their loved one. Yet, too few Canadian adults, caregivers included, are immunizing themselves against influenza and other preventable diseases.”

Among the top insights uncovered at the roundtable were the centrality of caregivers to the health and wellbeing of families, to the efficient functioning of the Canadian healthcare system, and to the Canadian economy overall. At the same time, the importance of caregivers – and the risks posed to them by infectious diseases like influenza – has largely gone underrecognized across the system and even by caregivers themselves.

The COVID-19 pandemic brought both caregivers and vaccination to the forefront of national and global attention, yet, the expert discussion revealed, the pandemic has also made it more difficult to adequately support caregivers and identify them as partners in care.

Another important insight from the roundtable was a lack of self-recognition among many of Canada’s 8 million caregivers as “caregivers” and as individuals whose own health status is vital and vulnerable, nor awareness of what steps to take to protect their health.

In addition to a need for more nuanced and targeted communications, experts at the roundtable pointed to an opportunity now to bolster existing access points and create new ones, building on innovations and policy momentum from COVID-19 vaccination initiatives. “Access is key for vaccine coverage,” said Laura Tamblyn Watts, President and CEO of CanAge. “As we’ve seen during COVID-19, we need to make sure that people can get their flu vaccines not just in healthcare settings such as doctors’ offices, pharmacies, and long-term care, but also in workplaces and the communities. Our CanAge Vaccine Report shows clearly that access to flu vaccines depends on your province and in some cases, postal code.”

Experts at the GCOA roundtable called for three critical actions:

  • Collect evidence on the burden and cost of influenza on caregivers, the Canadian healthcare system and society and identify best practices that can reduce the burden.
  • Expand access to vaccines, including where vaccines can be administered and by whom, engaging employers in this effort.
  • Develop wide-reaching and targeted education materials in which caregivers can recognize themselves.

Latest Developments

We keep our members and partners in touch with the most recent updates and opinions in the worldwide dialogue on population longevity and related issues.

Global Coalition on Aging Workshop Calls on G7 Countries to Fund Pull Incentives to Spur Antibiotic Innovation

The Global Coalition on Aging, in partnership with JPMA, today announced the release of its workshop report on the AMR crisis facing G7 countries and the world, “The Value of Pull Incentives in Japan to Encourage Investment in Antibiotic Innovation to Solve the AMR Crisis.” If strong action is not taken to address AMR, we will lose the antibiotics we need to cure infections, which is likely to outpace cancer as a major cause of death, killing an estimated 10 million by 2050.

Our National Conversation on Aging

Now that President Biden officially declared his run for a second term, what are we to make of the countless warnings about his age? Clearly, voters have already considered age a major factor – Google Search results for ‘Biden age’ hit an all-time-high just before the 2020 election – and speculation has only heightened four years on. Unfortunately, these concerns are misguided and even dangerous because they conflate age with poor health and confuse ideas about work and retirement.

World Immunization Week: Best-Kept Secret for 21st-Century Healthy Aging

The tremendous success of childhood immunisation campaigns across the 20thcentury is one of the greatest triumphs of public health. Along with advances in sanitation and antibiotics, childhood immunisation has resulted in the miracle of modern longevity: the once extravagant prospect of growing old has become the norm. Now, in our 21st century, isn’t it our great challenge to build on this achievement by realising a healthy longevity?

South China Morning Post Letter to the Editor

Antimicrobial resistance is one of the defining global problems of our time. Drug-resistant bacterial infections killed an estimated 1.27 million people in 2019. By 2050, 10 million lives annually could be lost to antimicrobial resistance, and annual global gross domestic product could fall by between 1.1 per cent and 3.8 per cent. Fortunately, Chinese policymakers, physicians and patients have shown what is possible when they focus collective efforts on antimicrobial resistance.

Medicine Price Setting Might Appeal to Voters but Will Cost Patients

As policymakers search for potential cuts to the national budget, they risk jeopardizing the country’s most cost-effective use of healthcare dollars: biomedical innovation regarding vaccines , prescription drugs, and emerging therapies, including antibodies. As the nation rapidly ages, protecting this pipeline of medicine will not only improve health outcomes but will do so at a lower cost by reducing more expensive hospital and primary care.

Global Coalition on Aging Hosts Cross-Sector Roundtable to Tackle Heart Valve Disease in Aging Societies

The Global Coalition on Aging (GCOA) and the Global Heart Hub have released a global position paper “Heart Valve Disease: Harnessing Innovation to Save Lives, Mitigate Costs, and Advance the Healthy Aging Agenda.” The report builds upon on a December 2022 GCOA-GHH roundtable of cross-sector experts and examines how behavior and policy change can best address heart valve disease in our 21st century.

New York City Twins with Ireland to Develop Age Friendly Communities

The twinning commits both sides to share knowledge on age friendly programs and builds on the 2011 Dublin Declaration of Age-Friendly Cities and Communities. The agreement was signed by the Cathaoirleach (Mayor) Nick Killian of Meath County Council which hosts the Irish Age Friendly Programme and Lorraine Cortés-Vázquez, Commissioner for Aging.

Just Getting Started at 75

In the latest charge against the promise of healthy aging, Dr. Ezekiel Emanuel, oncologist and bioethicist, doubled down on his infamous 2014 essay stating that 75 is the ideal age to die. Now 65, he maintains that after age 75, he will no longer receive medical screenings and interventions like colonoscopies, cancer treatment, flu shots, and heart valve replacement.